You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell depleted Stem Cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in New York (drug, biological, procedure)

Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS

Recruiting
  • Immunodeficiencies
  • Immune Dysregulation Syndromes
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 8, 2022

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
Has Results
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

Completed
  • Haematological Malignancies
  • CD25/71 allodepleted donor T-cells
  • London, United Kingdom
  • +1 more
Jul 18, 2022

Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland

Not yet recruiting
  • Allogeneic Stem Cell Transplant Candidate
  • +4 more
  • Cellular therapy product
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 1, 2022

Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

Not yet recruiting
  • Graft Vs Host Disease
  • +5 more
  • CliniMACS® device
  • (no location specified)
Jul 20, 2023

Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using

Recruiting
  • Relapsed Pediatric ALL
  • +2 more
  • In Vitro T cells depletion using CliniMCAS system
  • Shanghai, China
    Shanghai Children's Medical Center
Sep 28, 2022

Hematologic Diseases Trial in Palo Alto (biological, device, drug)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • +2 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Mar 25, 2022

Sickle Cell Disease Trial in Chicago (aß+ T-cell depletion with Miltenyi CliniMACS system)

Recruiting
  • Sickle Cell Disease
  • αβ+ T-cell depletion with Miltenyi CliniMACS system
  • Chicago, Illinois
    The University of Chicago
May 13, 2022

Multiple Myeloma Trial in New York (busulfan, melphalan and fludarabine)

Completed
Has Results
  • Multiple Myeloma
  • busulfan, melphalan and fludarabine
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 4, 2021

Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent

Available
  • Hematologic Malignancies
  • +2 more
  • CliniMACS CD34 Reagent System
  • Durham, North Carolina
    Duke University Medical Center
Nov 12, 2021

Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

Recruiting
  • Hematopoietic Organs; Disorder
  • CD62L depleted donor lymphocyte infusion
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Sep 6, 2023

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Leukemia, Bone Marrow Failure Syndrome, Immunodeficiencies Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using

Available
  • Leukemia
  • +2 more
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 2, 2021

Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

Not yet recruiting
  • Blood Disease
  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System
  • (no location specified)
Jan 30, 2023

Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

Recruiting
  • Hematologic Malignancy
  • CD45RA depleted donor lymphocyte infusion (DLI)
  • Tuebingen,, Germany
  • +1 more
Jul 13, 2023

Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Total-Body Irradiation
  • +8 more
  • Los Angeles, California
  • +9 more
Aug 19, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +3 more
  • total body irradiation
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 17, 2021

Myeloid Diseases Trial in Middletown, New York (drug, radiation, procedure)

Recruiting
  • Myeloid Diseases
  • Antithymocyte globulin (Rabbit)
  • +5 more
  • Middletown, New Jersey
  • +1 more
Jan 19, 2023

Acute Leukemia, Acute Myeloid Leukemia, MDS Trial in Philadelphia (CliniMACS Cell Processing System for TCRaß + T Cell and

Recruiting
  • Acute Leukemia
  • +7 more
  • CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Mar 21, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (ATIR101, Haploidentical

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • ATIR101
  • +3 more
  • Brugge, Belgium
  • +10 more
May 17, 2021

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (ATIR)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • ATIR
  • Brugge, Belgium
  • +7 more
Mar 17, 2021

Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

Active, not recruiting
  • Leukemia
  • +3 more
  • Palifermin
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

Recruiting
  • Lymphoid Leukemia, Acute
  • +2 more
  • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc
May 24, 2022

Leukemia, Myelocytic, Acute Trial in United States (CD34+ selection with CliniMACS device)

Completed
Has Results
  • Leukemia, Myelocytic, Acute
  • CD34+ selection with CliniMACS device
  • Duarte, California
  • +7 more
Oct 21, 2021